{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:05:51Z","timestamp":1781766351569,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nmd.2025.106210","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T23:05:56Z","timestamp":1756335956000},"page":"106210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Risdiplam and nusinersen in spinal muscular atrophy: a descriptive real-world study on motor function outcomes in northwestern Iran"],"prefix":"10.1016","volume":"54","author":[{"given":"Mohammad","family":"Barzegar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Poorshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatereh","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahideh","family":"Toopchizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Shiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.nmd.2025.106210_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511939","article-title":"Spinal muscular atrophy: the past, present, and future of diagnosis and treatment","volume":"24","author":"Nishio","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2025.106210_bib0002","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","article-title":"A multi-source approach to determine SMA incidence and research ready population","volume":"264","author":"Verhaart","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2025.106210_bib0003","series-title":"Healthcare","article-title":"Real World Evidence on the Effectiveness of Nusinersen within the National Program to Treat Spinal Muscular Atrophy in Poland","year":"2023"},{"issue":"6","key":"10.1016\/j.nmd.2025.106210_bib0004","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archneurol.2010.373","article-title":"Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year","volume":"68","author":"Kaufmann","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2025.106210_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1294405","article-title":"Study on the efficacy, safety, and biomarkers of nusinersen in type II and III spinal muscular atrophy in children","volume":"11","author":"Chen","year":"2023","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.nmd.2025.106210_bib0008","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/brainsci13101419","article-title":"Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: a Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"13","author":"Qiao","year":"2023","journal-title":"Brain Sci"},{"issue":"3","key":"10.1016\/j.nmd.2025.106210_bib0009","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/jpm14030244","article-title":"Switching from Nusinersen to Risdiplam: a Croatian Real-World Experience on Effectiveness and Safety","volume":"14","author":"Belan\u010di\u0107","year":"2024","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.nmd.2025.106210_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/phar.2866","article-title":"Efficacy of risdiplam in spinal muscular atrophy: a systematic review and meta-analysis","volume":"44","author":"Pascual-Morena","year":"2024","journal-title":"Pharmacother: J Hum Pharmacol Drug Ther"},{"issue":"5","key":"10.1016\/j.nmd.2025.106210_bib0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/13543784.2022.2056836","article-title":"Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing modifier for spinal muscular atrophy (SMA)","volume":"31","author":"Markati","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"10.1016\/j.nmd.2025.106210_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16309","article-title":"Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: an international study","volume":"31","author":"Coratti","year":"2024","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2025.106210_bib0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/archdischild-2021-323605","article-title":"New treatments in spinal muscular atrophy","volume":"108","author":"Gowda","year":"2023","journal-title":"Arch Dis Child"},{"issue":"7","key":"10.1016\/j.nmd.2025.106210_bib0016","doi-asserted-by":"crossref","first-page":"7S40","DOI":"10.1016\/S0929-693X(20)30276-1","article-title":"State of the art for motor function assessment tools in spinal muscular atrophy (SMA)","volume":"27","author":"Vuillerot","year":"2020","journal-title":"Arch P\u00e9diatrie"},{"issue":"5","key":"10.1016\/j.nmd.2025.106210_bib0017","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.27384","article-title":"Different trajectories in upper limb and gross motor function in spinal muscular atrophy","volume":"64","author":"Coratti","year":"2021","journal-title":"Muscle Nerve"},{"issue":"17_supplement_2","key":"10.1016\/j.nmd.2025.106210_bib0018","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1212\/WNL.0000000000203570","article-title":"SUNFISH Parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)(S34. 009)","volume":"100","author":"Servais","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nmd.2025.106210_bib0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(21)00367-7","article-title":"Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"21","author":"Mercuri","year":"2022","journal-title":"Lancet Neurol"},{"issue":"18","key":"10.1016\/j.nmd.2025.106210_bib0020","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2025.106210_bib0021","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/j.nmd.2023.07.385","article-title":"P08 Long-term comparative efficacy and safety of risdiplam versus nusinersen in children with Type 1 spinal muscular atrophy (SMA)","volume":"33","author":"Sajeev","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.106210_bib0022","first-page":"1","article-title":"Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy","author":"Kokaliaris","year":"2024","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.nmd.2025.106210_bib0023","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/biomedicines11041005","article-title":"Examination of Upper Limb Function and the Relationship with Gross Motor Functional and Structural Parameters in Patients with Spinal Muscular Atrophy","volume":"11","author":"Bieniaszewska","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.nmd.2025.106210_bib0024","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s40120-024-00653-2","article-title":"Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: systematic Review and Meta-analysis","volume":"13","author":"Hagenacker","year":"2024","journal-title":"Neurol Ther"},{"issue":"2","key":"10.1016\/j.nmd.2025.106210_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/medicina58020213","article-title":"The safety and efficacy of nusinersen in the treatment of spinal muscular atrophy: a systematic review and meta-analysis of randomized controlled trials","volume":"58","author":"Abbas","year":"2022","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"10.1016\/j.nmd.2025.106210_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16099","article-title":"Evaluation of risdiplam efficacy in 5q spinal muscular atrophy: a systematic comparison of electrophysiologic with clinical outcome measures","volume":"31","author":"Kessler","year":"2024","journal-title":"Eur J Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500937X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500937X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T03:04:36Z","timestamp":1763521476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089662500937X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":22,"alternative-id":["S096089662500937X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106210","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risdiplam and nusinersen in spinal muscular atrophy: a descriptive real-world study on motor function outcomes in northwestern Iran","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106210"}}